







Glycanbiosynthesisinvolvesenzymaticprocesses thatcreatecomplexcarbohydratestructures essentialforbiologicalfunctions,includingcell signaling,immuneresponsemodulation,and proteinfolding.KeyglycantypesincludeN-glycans (attachedtoasparagineresidues)andO-glycans (linkedtoserine/threonine),whicharecriticalin biopharmaceuticalqualitycontrolanddisease biomarkerdiscovery.
The market growth is driven by increasing gold mining activities, particularly in Asia-Pacific and Africa, where cyanide leaching remains the dominant extraction method. However, environmental concerns and stringent regulations pose challenges to market expansion.
Global glycan biosynthesis market is experiencing significant growth due to rapid advancements in glycomics research. Glycans play crucial roles in biological processes including cell signaling, immune response, and disease progression. As research uncovers more therapeutic applications of glycans, investment in biosynthesis technologies has surged. Recent studies demonstrate that over 50% of human proteins are glycosylated, highlighting the immense potential for glycanbased therapies.
The cell and gene therapy revolution presents significant opportunities for glycan biosynthesis technologies. Glycoengineering of cell surfaces is emerging as a powerful strategy to enhance therapeutic cell homing, persistence, and immune evasion. Engineered glycans can improve the targetingandefficacyofviralvectorsused in gene therapy. The market potential is substantial, with the cell therapy sector alone projected to exceed $20 billion withinfiveyears,creatingrobustdemand forglycanmodificationtechnologies.
he increasing demand for biopharmaceuticals is a major driver for theglycanbiosynthesismarket.Over70% of therapeutic proteins are glycosylated, making glycan analysis essential for drug development. The global biopharmaceutical market is projected to reach $500 billion by 2025, creating substantial demand for glycan analysis services. Monoclonal antibodies, which account for nearly 40% of biopharmaceutical products, require detailed glycan profiling to ensure proper biological activity and minimize immunogenicity.
North America is a leading region in the glycan biosynthesis market, driven by advanced biopharmaceutical research and strong government funding for glycobiology studies. The U.S. dominates the market, with significant investments in glycan-based therapeutics, particularly in oncology and immunology. The presence of key pharmaceutical companies and research institutions, such as the National Institutes of Health (NIH), accelerates innovation.
Europe holds a substantial share of the glycan biosynthesis market, supported by a well-established biopharmaceutical sector and strong academic research in glycobiology. The European Union’s Horizon Europe program funds glycobiology research, fostering innovation in glycan-based therapeutics. Germany and the UK are key contributors, with a focus on glycosylation analysis for biopharmaceutical quality control.
• Medicinal Chemistry Pharmaceuticals (Spain)
• Asparia Glycomics (Spain)
• Creative Biolabs (U.S.)
• Danaher Corporation (U.S.)
• Thermo Fisher Scientific (U.S.)
• Bio-Techne Corporation (U.S.)
These companies represent some of the major key players driving innovation and growth in the market, contributing significantly to global supply and competitive dynamics.
Founded in 2015, 24chemicalresearch is a trusted name in global chemical industry intelligence. We specialize in delivering high-quality market research reports, empowering over 30+ Fortune 500 clients with data-driven insights for strategic growth. Our team of experienced analysts delivers customized, reliable, and timely research backed by a rigorous methodology. From mining regulatory trends to forecasting market opportunities, our reports help companies navigate industry challenges, stay competitive, and grow confidently.
As a one-stop platform for the chemical sector, we offer:
• Deep specialization in chemical market analysis
• Customized reports tailored to your needs
• A robust portal with free samples, consulting, and competitive insights